shutterstock_157775444

Social media and mobile apps: Bringing people and clinical trials together

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …

Pfizer’s breast cancer drug gets EU approval

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance

Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …

novavax

Novavax cuts works force by a third in struggle to restructure

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses

Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …

apps_mobile

Chinese FDA releases “drug scanner” app

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Food and Drug Administration, app

The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …

janssen_stairs

Collaboration on new therapeutic vaccine for HIV shows promise

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Janssen, Johnson & Johnson

Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …

Pfizer to shut two out of three manufacturing plants in UK

November 9, 2016
Manufacturing and Production, Research and Development Pfizer, UK, manufacturing, production, sites

Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …

amgen_hq

NICE turns down Amgen’s multiple myeloma drug

November 9, 2016
Research and Development, Sales and Marketing Amgen, Kyprolis, NICE

Amgen has seen its drug Kyprolis (carfilzomib) rejected by NICE for its routine use in the treatment of multiple myeloma …

valeant

Valeant’s tough year gets worse with Q3 loss of $1.22 billion

November 9, 2016
Research and Development Q3, Valeant, loss

It’s easy to say that Valeant hasn’t had a great year so far. Unfortunately for those concerned, the outlook for …

code

BenevolentAI announces licensing agreement with Janssen

November 8, 2016
Research and Development Janssen, Johnson & Johnson, artificial intelligence

BenevolentAI, a British artificial intelligence company, announced a licensing agreement to develop a select number of drug candidates with Janssen, …

irina_antonijevic_image

Irina Antonijevic appointed as chief medical officer at vasopharm

November 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

vasopharma, a privately held biopharmaceutical company, announced on 8 November that it had appointed Irina Antonijevic as their chief medical …

cvnef_xxeaeoa4i

Free Pharmacovigilance Webinar: Only one day left to register!

November 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmacovigilance

There is only one more day to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

digital_pharma

FDA clears digital sensor for GSK inhaler

November 8, 2016
Manufacturing and Production, Sales and Marketing FDA, GSK, GlaxoSmithKline, Propeller Health, ellipta

The FDA has given 510(k) clearance to a smart inhaler sensor developed by Propeller Health for use with GlaxoSmithKline’s Ellipta …

abbott_humira

Coherus knocked back by AbbVie’s Humira patent protection

November 8, 2016
Manufacturing and Production, Sales and Marketing AbbVie, Coherus, Humira

Coherus Biosciences, a developer of biosimilars, has suffered a blow in their petition for Inter Partes Review (IPR) of one …

sicorbio

Teva antihypertensive generic duo gets FDA thumbs up

November 7, 2016
Manufacturing and Production, Sales and Marketing Azor, FDA, Teva, Tribenzor

Teva has received the approval from the US Food and Drug Administration (FDA) for its generic hypertension treatments Tribenzor (olmesartan …

oystein_soug

Targovax announce the appointment of CEO

November 7, 2016

Oystein Soug was announced as the new CEO of Targovax, a clinical stage immuno-oncology company dedicated to the development of …

biogen_austria_238

Biogen and Ionis’ spinal muscular atrophy drug meets primary endpoint

November 7, 2016
Manufacturing and Production, Research and Development Biogen, Ionis, spinal muscular atrophy

Biogen and Ionis Pharmaceuticals have released news that their investigational treatment for spinal muscular atrophy (SMA), Spinraza (nusinersen), met the …

banner_3

Free Pharmacovigilance Webinar: Just two days left to register!

November 7, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

There are only two more days to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

south_korea_flag

South Korea’s workforce expands 27% in last four years

November 7, 2016
Manufacturing and Production, Sales and Marketing Employment, manufacturing, production, south korea

South Korea’s pharmaceutical workforce has expanded by 27% in the last four years. The growth in jobs is can be …

shutterstock_274590824

GSK launches patent infringement action against Pfizer

November 7, 2016
Sales and Marketing Bexsero, trumenba

GlaxoSmithKline has filed a patent infringement lawsuit against rival Pfizer over the alleged copying of its popular meningococcal group B …

The Gateway to Local Adoption Series

Latest content